AMLX: Amylyx Pharmaceuticals, Inc.
About
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.
Current Value
$5.221 Year Return
Current Value
$5.221 Year Return
Key Details
Market Cap
$357.82M
P/E Ratio
-1.37
1Y Stock Return
-58.70%
1Y Revenue Growth
-33.22%
Dividend Yield
0.00%
Price to Book
1.8
Strategies that include AMLX
Stock's related to AMLX
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| RWAY | 51.95% | $394.72M | -17.18% | 15.47% |
| CHMI | 40.72% | $84.12M | -31.97% | 22.58% |
| DKL | 34.20% | $2.03B | -18.84% | 10.94% |
| AMPY | 33.14% | $260.89M | +7.01% | 0.00% |
| OCUL | 30.38% | $1.40B | +307.31% | 0.00% |
| DOMO | 29.49% | $338.79M | -3.94% | 0.00% |
| WOW | 25.94% | $434.90M | +18.48% | 0.00% |
| IPI | 25.68% | $356.20M | +40.21% | 0.00% |
| NTLA | 25.15% | $1.44B | -50.35% | 0.00% |
| YEXT | 24.79% | $996.50M | +15.58% | 0.00% |
| SWTX | 24.46% | $2.82B | +79.34% | 0.00% |
| HD | 24.06% | $404.07B | +33.23% | 2.18% |
| CRBU | 24.04% | $180.20M | -62.45% | 0.00% |
| USFD | 23.99% | $15.49B | +56.86% | 0.00% |
| PRA | 23.87% | $830.78M | +27.17% | 0.00% |
| ABCL | 23.80% | $800.44M | -37.56% | 0.00% |
| VEEV | 23.59% | $33.99B | +18.99% | 0.00% |
| MRVL | 23.39% | $77.39B | +63.39% | 0.27% |
| LNTH | 23.35% | $5.52B | +16.60% | 0.00% |
| PDSB | 23.18% | $78.37M | -66.59% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| JBT | -<0.01% | $3.76B | +11.25% | 0.34% |
| OII | -0.01% | $2.78B | +32.07% | 0.00% |
| JJSF | 0.02% | $3.21B | -0.70% | 1.81% |
| XOM | -0.03% | $521.39B | +13.56% | 3.22% |
| RBRK | -0.03% | $8.03B | +38.16% | 0.00% |
| JBSS | 0.04% | $949.98M | -9.36% | 1.04% |
| MANU | 0.04% | $2.88B | -9.41% | 0.00% |
| WKC | -0.04% | $1.61B | +30.46% | 2.33% |
| KVUE | 0.05% | $45.42B | +19.05% | 3.43% |
| COR | 0.06% | $47.48B | +21.20% | 0.86% |
| EXLS | 0.07% | $7.12B | +59.40% | 0.00% |
| BSAC | -0.08% | $9.08B | +1.53% | 4.01% |
| OMCL | 0.09% | $1.96B | +30.61% | 0.00% |
| FARM | 0.11% | $41.47M | -25.00% | 0.00% |
| TCTM | -0.11% | $8.10M | -42.99% | 0.00% |
| SQ | -0.12% | $56.87B | +57.53% | 0.00% |
| ANGI | 0.13% | $987.36M | -5.71% | 0.00% |
| CIVI | 0.14% | $4.91B | -21.31% | 3.94% |
| NNE | -0.14% | $833.66M | +531.50% | 0.00% |
| EVER | 0.14% | $664.25M | +124.76% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SWBI | -46.82% | $592.05M | -5.38% | 3.79% |
| WLDN | -30.92% | $598.47M | +113.45% | 0.00% |
| GIFI | -29.32% | $114.47M | +68.27% | 0.00% |
| CLAR | -27.47% | $163.42M | -17.76% | 2.35% |
| LTRN | -24.45% | $33.22M | -22.61% | 0.00% |
| GRFS | -23.74% | $2.18B | -11.41% | 0.00% |
| JYNT | -19.11% | $164.07M | +24.57% | 0.00% |
| HCI | -18.94% | $1.16B | +29.00% | 1.48% |
| DXPE | -13.56% | $1.07B | +119.39% | 0.00% |
| CCCS | -12.05% | $7.37B | +2.97% | 0.00% |
| EQNR | -12.02% | $64.72B | -22.63% | 5.56% |
| NMM | -11.30% | $1.58B | +126.51% | 0.38% |
| MFG | -11.20% | $63.12B | +43.52% | 1.44% |
| BTCT | -10.97% | $42.61M | +353.33% | 0.00% |
| TBRG | -10.95% | $244.47M | +52.66% | 0.00% |
| RAMP | -10.00% | $1.86B | -16.17% | 0.00% |
| HNST | -9.96% | $739.03M | +360.38% | 0.00% |
| MNOV | -9.45% | $93.19M | +2.15% | 0.00% |
| OCX | -9.42% | $42.93M | -36.09% | 0.00% |
| NERV | -9.32% | $14.69M | -58.00% | 0.00% |
ETF's related to AMLX
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XPH | 37.14% | $157.87M | 0.35% |
| XBI | 25.79% | $6.58B | 0.35% |
| GNOM | 25.13% | $70.59M | 0.5% |
| FMAT | 24.55% | $556.09M | 0.084% |
| IBB | 24.50% | $6.66B | 0.45% |
| FBT | 24.33% | $1.11B | 0.56% |
| XLB | 24.27% | $5.72B | 0.09% |
| IVOG | 23.87% | $1.12B | 0.15% |
| VIG | 23.80% | $87.09B | 0.06% |
| QQEW | 23.76% | $1.90B | 0.57% |
| VAW | 23.76% | $3.00B | 0.1% |
| LRGF | 23.76% | $2.28B | 0.08% |
| QDF | 23.74% | $1.88B | 0.37% |
| IJK | 23.50% | $9.56B | 0.17% |
| ARKG | 23.45% | $1.13B | 0.75% |
| MDYG | 23.42% | $2.80B | 0.15% |
| GRPM | 23.40% | $582.50M | 0.35% |
| VO | 23.39% | $73.70B | 0.04% |
| YYY | 23.18% | $538.03M | 4.6% |
| SWAN | 23.14% | $268.65M | 0.49% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| ICLO | -0.10% | $209.30M | 0.2% |
| CTA | -0.17% | $350.27M | 0.78% |
| TBIL | 0.44% | $4.38B | 0.15% |
| AGGH | 0.46% | $253.02M | 0.33% |
| FLRN | 0.52% | $2.33B | 0.15% |
| CLOI | -0.60% | $715.40M | 0.4% |
| IVOL | 0.61% | $548.70M | 1.02% |
| MINT | 0.63% | $11.62B | 0.35% |
| FMF | 0.69% | $244.61M | 0.95% |
| BOXX | -0.70% | $4.43B | 0.1949% |
| IBDQ | 0.82% | $2.89B | 0.1% |
| SEIX | 0.84% | $268.81M | 0.62% |
| SGOV | 0.86% | $27.53B | 0.09% |
| HDRO | -0.93% | $164.26M | 0.3% |
| BSCP | 0.95% | $4.05B | 0.1% |
| IBTE | 1.00% | $1.70B | 0.07% |
| KCCA | -1.20% | $220.51M | 0.87% |
| FLOT | 1.21% | $7.31B | 0.15% |
| DBO | 1.29% | $217.57M | 0.77% |
| DFSD | 1.33% | $3.63B | 0.16% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -12.99% | $195.31M | 0.85% |
| DBA | -12.02% | $755.88M | 0.93% |
| AGZD | -11.83% | $142.76M | 0.23% |
| SOYB | -10.78% | $27.32M | 0.22% |
| BTAL | -10.42% | $388.04M | 1.43% |
| USDU | -10.26% | $201.97M | 0.5% |
| WEAT | -9.49% | $120.27M | 0.28% |
| UUP | -7.86% | $309.25M | 0.77% |
| JUCY | -6.95% | $324.29M | 0.6% |
| MSOS | -6.87% | $632.80M | 0.83% |
| JBBB | -5.85% | $1.26B | 0.49% |
| IBDP | -5.14% | $2.11B | 0.1% |
| CORN | -4.88% | $61.12M | 0.2% |
| EQLS | -4.73% | $76.08M | 1% |
| KMLM | -3.58% | $353.87M | 0.9% |
| KRBN | -3.27% | $242.47M | 0.85% |
| TAIL | -2.00% | $67.98M | 0.59% |
| XBIL | -1.53% | $637.70M | 0.15% |
| XHLF | -1.49% | $874.27M | 0.03% |
| KCCA | -1.20% | $220.51M | 0.87% |
News
Yahoo
Amylyx Pharmaceuticals ( NASDAQ:AMLX ) Third Quarter 2024 Results Key Financial Results Revenue: US$416.0k (down 100...
SeekingAlpha
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2024 Earnings Call Transcript November 7, 2024 8:00 AM ETCompany ParticipantsLindsey Allen - Head of Investor...
Yahoo
Amylyx Pharmaceuticals Inc (AMLX) showcases promising clinical progress and a strong cash position, despite facing revenue shortfalls and regulatory hurdles.
Yahoo
Q3 2024 Amylyx Pharmaceuticals Inc Earnings Call
Yahoo
CAMBRIDGE, Mass., November 07, 2024--Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results
Yahoo
CAMBRIDGE, Mass., November 04, 2024--Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.